CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...

BofA analyst Michael Ryskin raised the firm’s price target on 10x Genomics (TXG) to $18 from $15 and keeps a Neutral rating on the shares. The firm is updating it price targets for Life Sciences & ...

In 1950, when computing was little more than automated arithmetic and simple logic, Alan Turing asked a question that still reverberates today: can machines think? It took remarkable imagination to ...

Environmental and chemical exposures have emerged as critical contributors to the global cancer burden. Sources such as dietary contaminants, food ...

A published image of a 10X prototype in Bordeaux appears to show ground tests underway According to sources, the Dassault Falcon 10X is expected to begin flight testing in 2026.

Learn about the latest research in spatial biology and its applications. From the mechanisms of disease to early diagnostics and therapeutics, hear the outstanding advancements in the field.